MiraLAX was initially approved by the FDA as a prescription drug laxative medicine. In 2006 the FDA approved “over-the-counter use of MiraLAX (polyethylene glycol 3350) powder for solution for the treatment of occasional constipation (irregularity)”. Despite the fact that MiraLAX is not intended for use by young children, pediatricians and … [Read more...]